In the last year, the FDA has approved five new Parkinson’s treatments. In order of approval date, these are: • Crexont – Immediate- and extended‑release levodopa carbidopa in one capsule; treats motor symptoms, potentially with fewer doses per day • Vyalev – A 24‑hour continuous, under-the-skin levodopa carbidopa infusion that eases motor symptoms, dyskinesia and fluctuations (ups and downs) • Onapgo – A 16-hour under-the-skin apomorphine infusion that eases motor symptoms and complications • A

488 reactions · 44 shares |  Understanding Dyskinesia in Parkinson’s...

3.7K views · 76 reactions | Dyskinesia is an involuntary movement...